Target Name: LAT2
NCBI ID: G7462
Review Report on LAT2 Target / Biomarker Content of Review Report on LAT2 Target / Biomarker
LAT2
Other Name(s): linker for activation of B-cells | linker for activation of T cells family member 2 | Linker for activation of B-cells | non-T-cell activation linker | WSCR5 | Membrane-associated adapter molecule | LAB | HSPC046 | Non-T-cell activation linker | OTTHUMP00000233173 | OTTHUMP00000179119 | OTTHUMP00000160648 | LAT2 variant 1 | WBSCR5 | OTTHUMP00000213098 | Linker for activation of T-cells family member 2 | Linker for activation of T cells family member 2, transcript variant 1 | membrane-associated adapter molecule | WBSCR15 | NTAL_HUMAN | OTTHUMP00000212052 | Williams-Beuren syndrome chromosomal region 5 protein | WBS15 | OTTHUMP00000179118 | linker for activation of T cells, transmembrane adaptor 2 | Williams-Beuren syndrome chromosomal region 15 protein | NTAL

LAT2: A Key Regulator of B-Cell Development and Activation

LAT2, or lysine-rich adaptor protein 2, is a protein that plays a crucial role in the development and activation of B-cells, which are a type of white blood cell that is responsible for producing antibodies to fight off infections. LAT2 is a key regulator of the B-cell receptor complex, which is responsible for recognizing and responding to foreign substances in the body.

Recent studies have suggested that LAT2 may be a drug target or biomarker for various diseases, including cancer, autoimmune disorders, and infections. In this article, we will explore the role of LAT2 in the development and activation of B-cells, as well as its potential as a drug target or biomarker.

The B-cell receptor complex is a complex of proteins that plays a critical role in the development and activation of B-cells. The B-cell receptor complex consists of several components, including the BCR (B cell receptor), which is responsible for recognizing and responding to foreign substances in the body, and the ITAM (Immunoglobulin transmembrane adaptor) protein, which helps to regulate the signaling process between the BCR and the cell surface.

LAT2 is a key regulator of the B-cell receptor complex. It is a protein that is expressed in many different tissues and cells, including the bone marrow, the spleen, and the lymph nodes. LAT2 is involved in the regulation of the expression and function of several B-cell surface proteins, including ITAMs, which are responsible for regulating the signaling process between the BCR and the cell surface.

One of the key functions of LAT2 is its ability to regulate the level of ITAMs on the cell surface. ITAMs are involved in the regulation of several different signaling pathways, including the T-cell signaling pathway and the pathway that involves the interaction between B-cells and antigens. By regulating the level of ITAMs on the cell surface, LAT2 is able to control the signaling process between the BCR and the cell surface, and thereby regulate the development and activation of B-cells.

In addition to its role in regulating ITAMs, LAT2 is also involved in the regulation of several other B-cell surface proteins. For example, LAT2 is involved in the regulation of the level of CD11b, which is a protein that is involved in the antigen presentation process. CD11b is important for the presentation of antigens to T-cells, and LAT2 is involved in regulating its level on the cell surface.

LAT2 is also involved in the regulation of several signaling pathways that are involved in the development and activation of B-cells. For example, LAT2 is involved in the regulation of the level of PKC (Ca2+-dependent protein kinase) activity, which is important for the regulation of several different signaling pathways that are involved in cell signaling.

In conclusion, LAT2 is a protein that plays a crucial role in the development and activation of B-cells. It is involved in the regulation of the expression and function of ITAMs, as well as several other B-cell surface proteins. LAT2 is also involved in the regulation of several signaling pathways that are involved in the development and activation of B-cells. As a result, LAT2 may be a drug target or biomarker for various diseases, including cancer, autoimmune disorders, and infections. Further research is needed to fully understand the role of LAT2 in these processes, and to develop effective treatments based on this knowledge.

Protein Name: Linker For Activation Of T Cells Family Member 2

Functions: Involved in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. May also be involved in BCR (B-cell antigen receptor)-mediated signaling in B-cells and FCGR1 (high affinity immunoglobulin gamma Fc receptor I)-mediated signaling in myeloid cells. Couples activation of these receptors and their associated kinases with distal intracellular events through the recruitment of GRB2

The "LAT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LAT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LATS1 | LATS2 | LAX1 | LAYN | LBH | LBHD1 | LBP | LBR | LBX1 | LBX1-AS1 | LBX2 | LBX2-AS1 | LCA5 | LCA5L | LCAL1 | LCAT | LCDR | LCE1A | LCE1B | LCE1C | LCE1D | LCE1E | LCE1F | LCE2A | LCE2B | LCE2C | LCE2D | LCE3A | LCE3B | LCE3C | LCE3D | LCE3E | LCE4A | LCE5A | LCE6A | LCIIAR | LCK | LCLAT1 | LCMT1 | LCMT2 | LCN1 | LCN10 | LCN12 | LCN15 | LCN1P1 | LCN1P2 | LCN2 | LCN6 | LCN8 | LCN9 | LCNL1 | LCOR | LCORL | LCP1 | LCP2 | LCT | LCT-AS1 | LCTL | LDAF1 | LDAH | LDB1 | LDB2 | LDB3 | LDC1P | LDHA | LDHAL6A | LDHAL6B | LDHAL6CP | LDHAP5 | LDHB | LDHBP1 | LDHC | LDHD | LDLR | LDLRAD1 | LDLRAD2 | LDLRAD3 | LDLRAD4 | LDLRAP1 | LDOC1 | LEAP2 | LECT2 | LEF1 | LEF1-AS1 | LEFTY1 | LEFTY2 | LEKR1 | LELP1 | LEMD1 | LEMD1-AS1 | LEMD2 | LEMD3 | LENEP | LENG1 | LENG8 | LENG8-AS1 | LENG9 | LEO1 | LEP | LEPR